Analysis Of Income And Expense [Abstract]

BioPorto - Filing #1413942

Concept 2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Analysis of income and expense [abstract]
Revenue [abstract]
Revenue
24,254,000 DKK
23,204,000 DKK
Material income and expense [abstract]
Research and development expense
30,258,000 DKK
28,125,000 DKK
Sales and marketing expense
17,381,000 DKK
20,786,000 DKK
Miscellaneous other comprehensive income [abstract]
Other comprehensive income, net of tax, exchange differences on translation of foreign operations and hedges of net investments in foreign operations [abstract]
Other comprehensive income, net of tax, exchange differences on translation of foreign operations
1,219,000 DKK
1,219,000 DKK
1,772,000 DKK
1,772,000 DKK
Comprehensive income, continuing and discontinued operations [abstract]
Comprehensive income
- DKK
- DKK
1,219,000 DKK
58,332,000 DKK
57,113,000 DKK
61,562,000 DKK
- DKK
59,790,000 DKK
1,772,000 DKK
- DKK

Talk to a Data Expert

Have a question? We'll get back to you promptly.